@article{b1c9d6cda5a442408ed43260c22b304b,
title = "Eligibility and cost for icosapent ethyl based on the reduce-it trial: Insight from the veterans affairs healthcare system",
keywords = "icosapent ethyl",
author = "Xiaoming Jia and Akeroyd, \{Julia M.\} and Khurram Nasir and Vijay Nambi and Ballantyne, \{Christie M.\} and Petersen, \{Laura A.\} and Virani, \{Salim S.\}",
note = "Funding Information: Dr Nasir serves on the advisory board of Regeneron. Dr Nambi serves as the site principle investigator on a study sponsored by Merck, holds a provisional patent on biomarkers for the prediction of heart failure along with Baylor College of Medicine and Roche, and is an event adjudicator on a study sponsored by Siemens. Dr Ballantyne has grant/research support (all significant; all paid to institution, not individual) from Akcea, Amarin, Amgen, Esperion, Novartis, Regeneron, Sanofi-Synthelabo, National Institute of Health, American Heart Association, and American Diabetes Association and is a consultant for Ak-cea, Amarin, Amgen, Astra Zeneca (significant), Eli Lilly, Esperion, Matinas Bi-oPharma Inc, Merck (significant), Novartis, Regeneron, and Sanofi-Synthelabo (significant). Dr Virani has grant funding from the Department of Veterans Affairs, the American Heart Association, the American Diabetes Association, and the Drs Tahira and Nuruddin Jooma Fund; receives honoraria from the American College of Cardiology (Associate Editor for Innovations ACC.org; significant) and the National Lipid Association; and serves on the steering committee for the Patient and Provider Assessment of Lipid Management (PALM) Registry at the Duke Clinical Research Institute (no financial remuneration). Funding Information: This work was supported by a Department of Veterans Affairs Health Services Research \& Development Service Investigator Initiated Grant (IIR 16–072), an American Heart Association Beginning Grant-in-Aid (14BGIA20460366), the American Diabetes Association Clinical Science and Epidemiology award (1-14-CE-44), and the Houston VA Health Services Research \& Development Center for Innovations grant (CIN13-413). The opinions expressed reflect those of the authors and not necessarily those of the Department of Veterans Affairs, the US government, or Baylor College of Medicine.",
year = "2019",
month = mar,
day = "5",
doi = "10.1161/CIRCULATIONAHA.118.038691",
language = "English (UK)",
volume = "139",
pages = "1341--1343",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "10",
}